NCT03775902View on ClinicalTrials.gov

Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Insulin Resistance
Interventions
DRUG

Placebo

placebo tablet

DRUG

Nicorandil

20 mg nicorandil (Ikorel, Sanofi Winthrop Industrie; NIC)

Trial Locations (1)

2100

University of Copenhagen, Copenhagen

All Listed Sponsors
lead

University of Copenhagen

OTHER

NCT03775902 - Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development | Biotech Hunter | Biotech Hunter